Conduit Pharmaceuticals Q1 EPS $(5.56) Up From $(3.67 thousand) YoY

Benzinga Newsdesk www.benzinga.com Positive 64.2%

Neg 0% Neu 0% Pos 64.2%

Conduit Pharmaceuticals (NASDAQ:CDT) reported quarterly losses of $(5.56) per share. This is a 99.85 percent increase over losses of $(3.67 thousand) per share from the same period last year.